Axsome Therapeutics (AXSM) had the highest return in March 2019 by a US stock with a market cap of $2B+, returning 78.5%.
| ASSET | MONTH | % RETURN |
|---|---|---|
Axsome Therapeutics (AXSM) | March 2019 | 78.54% |
Catalyst Pharmaceuticals (CPRX) | March 2019 | 74.06% |
Alphatec (ATEC) | March 2019 | 65.63% |
Ascendis Pharma A-S (ASND) | March 2019 | 59.98% |
Protagonist Therapeutics (PTGX) | March 2019 | 56.54% |
Nextdecade (NEXT) | March 2019 | 51.23% |
MongoDB (MDB) | March 2019 | 45.65% |
Krystal Biotech (KRYS) | March 2019 | 43.11% |
Immunitybio (IBRX) | March 2019 | 38.6% |
Soleno Therapeutics (SLNO) | March 2019 | 36.42% |
StoneCo (STNE) | March 2019 | 33.04% |
ELF Beauty (ELF) | March 2019 | 32.5% |
Natera (NTRA) | March 2019 | 29.6% |
Carvana (CVNA) | March 2019 | 28.76% |
Apellis Pharmaceuticals (APLS) | March 2019 | 27.45% |
Trip Group Ltd ADR (TCOM) | March 2019 | 26.38% |
Merus (MRUS) | March 2019 | 25.7% |
Futu (FUTU) | March 2019 | 25.47% |
Torm PLC Class A (TRMD) | March 2019 | 25.21% |
YETI (YETI) | March 2019 | 24.9% |
Zscaler (ZS) | March 2019 | 23.38% |
Veracyte (VCYT) | March 2019 | 23.25% |
Rev (REVG) | March 2019 | 22.76% |
Iridium Communications (IRDM) | March 2019 | 22.35% |
Abercrombie & Fitch (ANF) | March 2019 | 22.23% |
